ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2688 • 2015 ACR/ARHP Annual Meeting

    Socioeconomic Status, Ethnicity/Race, and Autoantibody Status in Rheumatoid Arthritis

    Mercedes Quinones1, Sharon Dowell1, Gail S. Kerr2, Christopher Swearingen3, Yusuf Yazici4, Luis Espinoza5, Ignacio Garcia-Valladares6, Edward L. Treadwell7, Theresa Lawrence Ford8, Yvonne Scherrer9, Angelia Mosley-WIlliams10, Rodolfo Perez Alamino11, Akgun Ince12, John Amatruda13 and Jorge Flautero Arcos14, 1Howard University Hospital, Washington, DC, 2Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, 3Pediatrics & Biostatistics, University of Arkansas, Little Rock, AR, 4Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 5Medicine-Section of Rheumatology, LSU Medical Center, New Orleans, LA, 6Immunology & Rheumatology, Hospital General de Occidente, Zapopan, Jalisco, Mexico, 7Dept Medicine Div of Rheum, E Carolina Univ Sch of Med, Greenville, NC, 8North Georgia Rheumatology Group, PC, Lawrenceville, GA, 9Center for Rheumatology & Immunology Arthritis, Fort Lauderdale, FL, 10John Dingell VAMC, Detroit, MI, 11Rheumatology, Lousiana State University and LSU Medical Center, New Orleans, LA, 12Arthitis Consultants Inc, St. Louis University, St. Louis, MO, 13Rheumatology, Howard University, Washington, DC, 14Rheumatology, Howard University Hospital, Washington, DC

    Background/Purpose: Ethnic disparities in outcomes of RA patients have been attributed to delayed presentation to specialty care and access to DMARDs, greater disease burden, and…
  • Abstract Number: 2689 • 2015 ACR/ARHP Annual Meeting

    Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity Are Multifactorial in Early Rheumatoid Arthritis

    Cécile Gaujoux-Viala1, Nathalie Rincheval2, Laure Gossec3, Francis Guillemin4, Maxime Dougados5, Jean-Pierre Daures6 and BG Combe7, 1Nîmes University Hospital, Rheumatology Department; EA 2415, Montpellier University, Nîmes, France, 2Biostatistic, EA 2415, Epidemiology unit, Montpellier, France, 3Rheumatology, Pitié Salpetriere Hospital, Paris, France, 4University of Lorraine, Nancy, France, 5Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP. INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France, 6Biostatistic, EA 2415 Epidemiology unit, Montpellier, France, 7Lapeyronie, Montpellier, France

      Background/Purpose: Patients and physicians often differ in their perceptions of rheumatoid arthritis (RA) disease activity, as quantified by the patient's global assessment (PGA) and by…
  • Abstract Number: 2690 • 2015 ACR/ARHP Annual Meeting

    The Effects of Disease of the Joints on Modified Health Assessment Questionnaire Scores in Rheumatoid Arthritis Patients: A Retrospective Study Using the National Database of Rheumatic Diseases By Ir-Net in Japan

    Kumiko Ono1, Satoru Ohashi2, Hiroyuki Oka3, Yuho Kadono4, Yasunori Omata5, Takumi Matsumoto6, Sakae Tanaka1 and Shigeto Tohma7, 1Orthopaedic Surgery and Spinal Surgery, The University of Tokyo Hospital, Tokyo, Japan, 2Department of Orhopaedic Surgery, Sagamihara Hospital, National Hospital Organization, Kanagawa, Japan, 3Department of Joint Disease Research, 22nd Century Medical & Research Center, faculty of medicine,the university of Tokyo, Tokyo, Japan, 4Department of Orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan, 5Department of Orthopaedic Surgery and Spine Surgery, The University of Tokyo Hospital, Tokyo, Japan, 6Department of orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan, 7Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan

    Background/Purpose: Few studies of which joints most affect physical function in rheumatoid arthritis (RA) patients have been conducted. The present study investigated the effect of…
  • Abstract Number: 2691 • 2015 ACR/ARHP Annual Meeting

    Musculoskeletal Ultrasound in Multi-Center Rheumatoid Arthritis Clinical Trials: Methodology for Optimizing Reliability of Acquisition and Real-Time Scoring

    Veena K. Ranganath1, Yossra Suliman1,2, Jenny Brook3, David Elashoff3, Ami Ben-Artzi4, Cesar Olmos1, Nabeel Borazan3, Thasia Woodworth1 and Gurjit S. Kaeley5, 1Medicine, Division of Rheumatology, David Geffen School of Medicine, Los Angeles, CA, 2Rheumatology and Rehabilitation department, Assiut university, Faculty of Medicine,, Assiut, Egypt, 3Medicine, David Geffen School of Medicine, Los Angeles, CA, 4David Geffen School of Medicine, Los Angeles, CA, 5University of Florida, Jacksonville, FL

    Background/Purpose: Rheumatoid arthritis (RA) musculoskeletal ultrasound (MSUS) literature reports good reliability of scoring still images with training, but inconsistent reliability of scoring during acquisition, likely…
  • Abstract Number: 2692 • 2015 ACR/ARHP Annual Meeting

    The Patients Evaluation of Pain and Disease Activity As Well As Improvement during One-Year Follow-up on Etanercept Treatment Is Highly Associated to Subjective Factors and Not to Objective Assessments Including Ultrasound

    Hilde Berner Hammer1 and Jon Lampa2, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Patient reported outcomes (PROs) are important for evaluation of treatment response in patients with rheumatoid arthritis (RA). Ultrasound (US) is a sensitive method for…
  • Abstract Number: 2693 • 2015 ACR/ARHP Annual Meeting

    Comparing Eight Year Clinical and Radiographic Outcome in Two Cohorts of Patients with Rheumatoid Arthritis

    Maria LE Andersson1, Kristina Forslind2 and Ingiäld Hafström3, 1R&D Centre Spenshult,Halmstad, Halmstad, Sweden, 2Department of Medicine, Helsingborgs Lasarett, Section of Rheumatology, Helsingborg, Sweden, 3Rheumatology Dept, Karoliska Institute, Stockholm, Sweden

    Background/Purpose: To compare patient and disease characteristics over the first 8 years of disease in a large inception cohort of early RA patients included 1992…
  • Abstract Number: 2694 • 2015 ACR/ARHP Annual Meeting

    Variations in the Metabolome in Response to Disease Activity of Rheumatoid Arthritis

    Zuzana Tatar1, Carole Migne2, Mélanie Petera3, Estelle Pujos Guillot4, Philippe Gaudin5,6, T Lequerré7, Hubert Marotte8, Jacques Tebib9 and Martin Soubrier1, 1Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, 2Metabolomic Plateform INRA, Theix-Clermont-Ferrand, France, 3Metabolomic Plateform, INRA, Theix -Clermont-Ferrand, France, 4Metabolomic Plateform, INRA, Theix-Clermont-Ferrand, France, 5Rheumatology, University Hospital, Grenoble, France, 6Rheumatology Department, CHU Hôpital Sud, Grenoble Teaching Hospital, Echirolles, France, 7Rheumatology Department and INSERM U 905, CHU Hôpitaux de Rouen, Rouen, France, 8INSERM 1059 / LBTO, Université de Lyon, Saint-Etienne; Rheumatology Department, Saint-Etienne, France, 9Rheumatology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite Lyon, France

    Background/Purpose: Anti-TNF-alpha therapies are able to control rheumatoid arthritis (RA) disease activity and to limit structural damage. Nevertheless, no predictive factor of response to anti-TNF-alpha,…
  • Abstract Number: 2695 • 2015 ACR/ARHP Annual Meeting

    Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis

    Youngkyun Kim1, Kijun Lee2, Hae-Rim Kim3, Sang Heon Lee4, Ji Hyeon Ju5 and HO-YOUN KIM6, 11Convergent Research Consortium for Immunologic Disease, The Catholic University of Korea, Seoul, South Korea, 2The Catholic University of Korea, Seoul, South Korea, 3Konkuk University Medical Center, Seoul, South Korea, 4Konkuk University Hospital, Seoul, South Korea, 5Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 6Konkuk university hospital, Seoul, South Korea

    Background/Purpose: The purpose of this study is to explore new biomarkers for early diagnosis of rheumatoid arthritis (RA). For better discrimination power, we especially investigated…
  • Abstract Number: 2696 • 2015 ACR/ARHP Annual Meeting

    Geography and Association Between Patient Reported Outcomes and Disease Activity (DAS28) Components in Patients with Rheumatoid Arthritis, Among 17 Countries

    Raluca Dumitru1, Elizabeth M.A. Hensor1, Ihsane Hmamouchi2, Paul Emery3, Maxime Dougados4 and Maya H. Buch5, 1University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom, 2El Ayachi Hospital, Rabat, Morocco, 3Academic Section of Musculoskeletal Disease, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom, 4Service de Rhumatologie B, GHU Cochin, F-75014 France, PARIS, France, 5Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom

    Background/Purpose: 28 joints-disease activity score (DAS28) is routinely used in clinical practice to assess disease activity in rheumatoid arthritis (RA). DAS28, particularly its subjective components…
  • Abstract Number: 2697 • 2015 ACR/ARHP Annual Meeting

    Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia

    Jayanth Doss1, Huan Mo2, Leslie J. Crofford1 and Joshua C. Denny2, 1Rheumatology, Vanderbilt University School of Medicine, Nashville, TN, 2Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN

    Background/Purpose: The differences between seronegative and seropositive rheumatoid arthritis (RA) have not been widely reported. We performed an electronic health record (EHR)-based phenome-wide association study…
  • Abstract Number: 2698 • 2015 ACR/ARHP Annual Meeting

    Follicular Helper T Cells in Peripheral Blood of Patients with Rheumatoid Arthritis

    Alicia Beatriz Costantino1, Laura Onetti2, Melina del Valle Cloquell3, Cristina del Valle Acosta1, Eduardo Mussano2, Isaac Ignacio Cadile2, Cecilia María Rodriguez3, Stefania Santo1 and Paola Virginia Ferrero1, 1Córdoba, Laboratorio de Inmunología. Hospital Nacional de Clínicas. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba, Córdoba, Argentina, 2Córdoba, Servicio de Reumatología. Hospital Nacional de Clínicas. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba, Córdoba, Argentina, 3Córdoba, Laboratorio de Oncohematología, Hospital Nacional de Clínicas, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina

    Background/Purpose: RA is an autoimmune, inflammatory and chronic disease which aetiology is unknown. It presents different autoantibodies such as RF and ACPA. A population of…
  • Abstract Number: 2699 • 2015 ACR/ARHP Annual Meeting

    Muscle Inflammation Relates to Disease Activity and Disability but Not Insulin Resistance in Rheumatoid Arthritis

    Ryan Jessee1, Rachel Narowski2, Monica Hubal3, Janet Huebner4, Virginia Kraus5, William Kraus6 and Kim Huffman2,7, 1Internal Medicine, Duke University Medical Center, Durham, NC, 2Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, 3Research and Education, George Washington University School of Medicine and Health Sciences, Washington, DC, 4Duke Molecular Physiology Institute,, Duke University Medical Center, Durham, NC, 5Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, 6Division of Cardiology, Duke University Medical Center, Durham, NC, 7Durham Veterans Affairs Medical Center, Durham, NC

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased cardiovascular disease, insulin resistance, and disability. Our objectives were to analyze levels of skeletal muscle inflammatory cytokines…
  • Abstract Number: 2700 • 2015 ACR/ARHP Annual Meeting

    Trabecular Thinning in Metacarpophalangeal Joints of Anticitrullinated Peptide Antibody Positive Patients with Arthralgia

    Kresten Krarup Keller1, Jesper Skovhus Thomsen2, Kristian Stengaard-Pedersen1, Andreas Wiggers Nielsen1, Berit Schiøtz-Christensen3, Lone Svendsen4, Merete Graakjær5, Peter Mosborg Pedersen6, Barbara Unger7, Bente Langdahl8 and Ellen-Margrethe Hauge1, 1Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Aarhus University, Aarhus, Denmark, 3Spine Centre of Southern Denmark, Middelfart, Denmark, 4Private Practice in Rheumatology, Skanderborg, Denmark, 5Clinic of Rheumatology Aarhus, Aarhus, Denmark, 6Randers Hospital, Randers, Denmark, 7Horsens Hospital, Horsens, Denmark, 8Endocrinology, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by synovitis leading to bone erosions and joint destruction, but little is known about bone structure in the joints…
  • Abstract Number: 2701 • 2015 ACR/ARHP Annual Meeting

    An Expansion of Rare Lineage Intestinal Microbes Characterize Rheumatoid Arthritis

    Jun Chen1, John M. Davis III2, Eric L. Matteson3 and Veena Taneja4, 1Health Sciences Research, Mayo Clinic, Rochesert, MN, 2Division of Rheumatology, Mayo Clinic, Rochester, MN, 3Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Immunology, Mayo Clinic, Rochester, MN

    Background/Purpose: The adaptive immune response in Rheumatoid arthritis (RA) is influenced by an interaction between host genetics and environment, particularly the host microbiome. To define…
  • Abstract Number: 2702 • 2015 ACR/ARHP Annual Meeting

    Immunophenotyping of Rheumatoid Arthritis Reveals the Linkage Between HLA-DRB1 Genotype, CXCR4 Expressions on Memory CD4+ T Cells, and Disease Activity

    Yasuo Nagafuchi1, Hirofumi Shoda1, Shuji Sumitomo1, Shinichiro Nakachi1, Rika Kato2, Yumi Tsuchida2, Haruka Tsuchiya2, Keiichi Sakurai2, Norio Hanata2, Shoko Tateishi2, Hiroko Kanda2, Keishi Fujio1 and Kazuhiko Yamamoto1, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Background/Purpose: The HLA-DRB1 is the strongest genetic risk factor for rheumatoid arthritis (RA). Although this fact suggests a pivotal role for adaptive immunity in RA,…
  • « Previous Page
  • 1
  • …
  • 1831
  • 1832
  • 1833
  • 1834
  • 1835
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology